Deze website is uitsluitend voorbehouden aan beroepsbeoefenaren in Nederland.

In patients with acquired TTP (aTTP), immune-mediated deficiency of ADAMTS13 results in dangerous microthrombi that cause:1-3

hemolytic-anemia

Severe thrombocytopenia
(platelets < 30x109/L)

diagnosing-severe-thrombo

Microangiopathic hemolytic anemia (MAHA)
Characterized by the presence of schistocytes

ischemia

Tissue ischemia
Lesions can occur in any organ, but most frequently affect the heart, brain and kidneys

The consequences of microthrombi can be serious, and aTTP may lead to acute thromboembolic events such as:1,4,7

heart
Myocardial infarction
brain
Stroke
artery
Arterial thrombosis
monitor
Early death

Signs and symptoms of aTTP1,2,4-6

Signs and symptoms aTTP

These symptoms are only a limited part of what can be observed during an TMA/ aTTP episode. The aspecific symptoms and the variety in phenotype must be taken into account.
Adapted from Scully, M. et al.4

icon

Skin


Petechiae, purpura, bruising

icon

Neurological


Headache, confusion, seizures, coma

icon

Cardiac


EKG abnormalities

icon

Gastrointestinal


Abdominal pain, diarrhea

icon

Kidney


Proteinuria/hematuria

1/5
icon

Skin


Petechiae, purpura, bruising

icon

Neurological


Headache, confusion, seizures, coma

icon

Cardiac


EKG abnormalities

icon

Gastrointestinal


Abdominal pain, diarrhea

icon

Kidney


Proteinuria/hematuria

1/2

Dr. Scully details the signs and symptoms of the disease

Neem contact op

Get in touch - dupixent
Wij staan klaar

Heeft u vragen of wilt u meer weten? Wij zorgen dat u zo snel mogelijk geholpen wordt.

Referenties
  1. Joly BS, et al. Thrombotic thrombocytopenic purpura. Blood. 2017;129(21):2836–46.

  2. Tsai H-M. Pathophysiology of thrombotic thrombocytopenic purpura. Int J Hematol. 2010;91(1):1-19

  3. Sadler JE. Pathophysiology of thrombotic thrombocytopenic purpura. Blood. 2017;130:1181–8.

  4. Scully M, Hunt BJ, Benjamin S, et al; British Committee for Standards in Haematology. Guidelines on the diagnosis and management of thrombotic thrombocytopenic purpura and other thrombotic microangiopathies. Br J Haematol. 2012;158(3):323-335

  5. Azoulay E, Bauer PR, Mariotte E, et al; Nine-i Investigators. Expert statement on the ICU management of patients with thrombotic thrombocytopenic purpura. Intensive Care Med. 2019;45(11):1518-1539

  6. Gallan AJ, Chang A. A new paradigm for renal thrombotic microangiopathy. Semin Diagn Pathol. 2020;37(3):121-126

  7. Goel R, et al. Prognostic risk-stratified score for predicting mortality in hospitalized patients with thrombotic thrombocytopenic purpura: nationally representative data from 2007 to 2012. Transfusion. 2016;56(6):1451-1458.

MAT-BE-2401121 - 1.0 - 12/2024